GNBT - Generex subsidiary inks distribution agreement with Nexgen Medical

Generex Biotechnology's (GNBT) subsidiary Olaregen Therapeutix announces that the company has executed a distribution agreement with Nexgen Medical to be the exclusive distributor for the Excellagen line of wound care products in Malaysia.Nexgen is coordinating the approval of Excellagen with the Malaysian Ministry of Health and expects commercial approval by the end of May 2021.Nexgen has committed to purchasing 1,000 units of Excellagen in year one, with an initial purchase of 500 units 0.8cc syringes.The distribution agreement will open the door to conduct business in Singapore, Thailand, Indonesia, Vietnam, Philippines, and other countries in Southeast Asia, the company said.

For further details see:

Generex subsidiary inks distribution agreement with Nexgen Medical